Eron, Joseph J <br/><br/>
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.  [electronic resource] 

 -  The Lancet. Infectious diseases  Jul 2013 
 - 587-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-4457 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(13)70093-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>CD4 Lymphocyte Count<br/>Double-Blind Method<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--isolation & purification<br/>Humans<br/>Male<br/>Middle Aged<br/>Placebos--administration & dosage<br/>Pyrrolidinones--administration & dosage<br/>Raltegravir Potassium<br/>Salvage Therapy--adverse effects<br/>Treatment Outcome<br/>Viral Load